Some private insurance providers sponsoring Medicare Part D marked up certain generic drugs an average of five times what it costs to acquire the drug.
Americans from across the political spectrum are worried about the cost of prescription drugs for serious diseases, following weeks of news coverage about companies hiking prices for critical medicines.